Novavax | NVAX - Interest Income

Novavax reported $303K in Interest Income for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Income Change
Adma Biologics ADMA:US USD 7.24K 4.97K
BioCryst Pharmaceuticals BCRX:US USD 2.7M 944K
Dynavax Technologies DVAX:US USD 4.32M 1.76M
Geron GERN:US USD 1.23M 383K
MannKind MNKD:US USD 957K 294K
Moderna Inc MRNA:US USD 87M 29M
Pain Therapeutics PTIE:US USD 1.55M 676K
Pfizer PFE:US USD 137M 67M
Sarepta Therapeutics SRPT:US USD 9.13M 4.35M